Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132150) titled 'Efficacy and Safety Evaluation of Perfluorohexyloctane Eye Drops in the Treatment of Post-LASIK dry eye disease: A Prospective, Parallel-Group, Randomized Controlled Trial' on Sept. 10.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: DaLian He Eye Hospital.Co.Ltd
Condition:
Dry eye disease
Intervention:
Perfluorohexyloctane combined with 0.2% Hylo-Comod? in the experimental group:Perfluorohexyloctane ophthalmic solution
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-12-01
Target Sample Size: Perfluorohexyloctane combined with 0.2% Hylo-Comod? in...